← All candidates
6 insider filings on record.
16 filings on record.
RAPTRAPT Therapeutics, Inc.
—
6 insider filings on record.
None of them an open-market buy in the last year.
No price data yet — the yfinance scanner hasn't produced bars for RAPT.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →Context
Coverage
GSK RAPT Acquisition Adds Food Allergy Asset To Immunology Growth StorySimply Wall St. · 03-07Assessing RAPT Therapeutics (RAPT) Valuation After A Sharp 3 Month Share Price SurgeSimply Wall St. · 03-01This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer EmergesMotley Fool · 02-25GSK Extends RSV Reach And Adds Food Allergy Assets With RAPT DealSimply Wall St. · 01-30
The file stays open
16 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice